Madam Speaker, I thank my colleague from Laval for her presentation on this important and very technical bill that has an impact on the entire scientific and medical community in Canada.
I want to refer specifically to a letter sent by Quebec's health minister, dated April 6, in which he states his opposition to the continuation of this bill's consideration because of its impact. Measures proposed in the bill would have major repercussions, especially on the management of medical laboratory and diagnostic services. This letter says, “Accordingly, the Government of Quebec is calling on the federal government to reconsider its approach to ensuring the biosafety and biosecurity of human pathogens and toxins, rather than pursuing the parliamentary work currently underway.”
That was exactly the amendment proposed by the Bloc Québécois in committee during the study at second reading. It was rejected.
I would ask my colleague what she thinks of the negotiation in good faith proposed by the current Conservative government regarding the harmonization of the QST and GST and this other situation where the Government of Quebec wants to be consulted before this bill is passed. What does she think about this attitude, especially considering that the Liberals are also thinking of supporting the bill?